1,637 results match your criteria: "Neurogastroenterology & Motility Stanford University Stanford[Affiliation]"
Gut Microbes
November 2024
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Front Med (Lausanne)
October 2024
College of Acupuncture-Moxibustion and Tuina, Guangxi University of Chinese Medicine, Nanning, China.
Objective: Gastroparesis is one of the complications of diabetes mellitus, which has a major impact on the quality of life of patients, and the limited therapeutic options currently available make it a public health problem. No bibliometric studies on diabetic gastroparesis have been published to date. Therefore, the aim of this paper is to summarize and analyze the research hotspots for researchers.
View Article and Find Full Text PDFJ Evid Based Integr Med
October 2024
Department of Psychology and Neuroscience, Baylor University, Waco, TX, USA.
J Neurogastroenterol Motil
October 2024
Digestive Disease Research Institute, Wonkwang University, Iksan, North Jeolla Province, Korea.
J Exp Med
January 2025
Senior Scientific Editor, JEM, Rockefeller University Press, New York, NY, USA.
Terez Shea-Donohue is the program director of the Division of Digestive Diseases and Nutrition at the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. As a program director, Terez supports basic and translational research related to neurogastroenterology, gastrointestinal (GI), and GI epithelial barrier function. We spoke to Terez about the transition from active research to a predominantly administrative job, the need for life-long mentorship, and the continued sex/gender bias in health care.
View Article and Find Full Text PDFNeurogastroenterol Motil
November 2024
Maastricht University Medical Center, Maastricht, The Netherlands.
World J Gastrointest Surg
September 2024
Department of Integrated Chinese and Western Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China.
Neurogastroenterol Motil
September 2024
Indiana University Bloomington, Bloomington, Indiana, USA.
This paper introduces a metric capable of tracking a hypothetical brainstem "switching" mechanism involved in regulating the afferent influence of blood pressure on the vagal efferent control of heart rate. In theory, this metric could be applied to evaluate the "efficiency" of brainstem pathways involved in common mechanisms of autonomic function involving the vagal influences on the gut as well as the heart. Thus, by exploring the dynamic "efficiency" of the brainstem feedback circuit linking heart rate to posture, a clinically relevant index of vagal flexibility might be extracted that would provide a generalizable window into the vagal regulation of both the heart and gut.
View Article and Find Full Text PDFAm J Gastroenterol
September 2024
Department of Gastroenterology-Hepatology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
Introduction: Real-time assessment of gastrointestinal (GI) symptoms in irritable bowel syndrome (IBS) using the experience sampling method (ESM) is suggested as a more appropriate approach than currently used end-of-day or end-of-week reports. This psychometric evaluation study assesses the validity and reliability of a previously developed ESM-based patient-reported outcome measure (PROM) for real-time GI symptom assessment in IBS.
Methods: This multicenter validation study included 230 Rome IV patients with IBS (80% female; mean age 41.
Nutrients
September 2024
Neurogastroenterology & Motility Unit, Gastroenterology Department, Great Ormond Street Hospital for Children, London WC1N 3JH, UK.
Normal and optimal functioning of the gastrointestinal tract is paramount to ensure optimal nutrition through digestion, absorption and motility function. Disruptions in these functions can lead to adverse physiological symptoms, reduced quality of life and increased nutritional risk. When disruption or dysfunction of neuromuscular function occurs, motility disorders can be classified depending on whether coordination or strength/velocity of peristalsis are predominantly impacted.
View Article and Find Full Text PDFGut Microbes
September 2024
Department of Medicine, Loyola University Chicago, Maywood, IL, USA.
This Meeting Summary highlights the key insights from the 12th meeting of the Gut Microbiota for Health World Summit, held in Washington, DC, organized by the American Gastroenterological Association (AGA) and the European Society of Neurogastroenterology and Motility (ESNM). Through a 2-day series of plenary sessions, workshops, a poster session, and live discussions involving thought leaders, physicians, researchers, and representatives from the Food and Drug Administration and the pharmaceutical industry, the conference attendees focused on the strategies and challenges in developing microbiome-based therapies to prevent and treat human disease. The conference highlighted progress in the field, including the recently successful introduction of 2 new fecal microbial transplantation-based products into the clinical setting, and the continuing development of next-generation probiotics.
View Article and Find Full Text PDFAm J Gastroenterol
September 2024
Neurogastroenterology Unit and Department of Gastroenterology, Royal North Shore Hospital, St Leonards, Australia.
Introduction: Obstetric anal sphincter injury (OASI) is associated with serious morbidity and reduced quality of life. The role of anorectal manometry (ARM) to guide treatment is unclear. We aimed to define the role of ARM and symptom assessment after OASI in predicting anal incontinence at long-term follow-up.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
July 2024
Associate Professor of Clinical Medicine Director, Program in Neurogastroenterology and Motility Division of Gastroenterology and Hepatology University of Pennsylvania Philadelphia, Pennsylvania.
J Pediatr Gastroenterol Nutr
December 2024
Center for Neurointestinal Health, MassGeneral Hospital, Boston, Massachusetts, USA.
Objectives: Little is known about the experience of adolescents and young adults (AYA) with disorders of gut-brain interaction (DGBI) who transition from pediatric to adult gastroenterology care. In this two-part study, we used quantitative and qualitative methods to: (1) assess incidence of optimal versus suboptimal transitions of care for AYA with DGBI, (2) characterize health and quality of life effects of the transition, and (3) identify barriers and facilitators for optimal transition of care.
Methods: In Part 1, we conducted a retrospective review of AYA referrals to our adult neurogastroenterology clinic who had transitioned from pediatric gastroenterology care (N = 109, 17-23 years, 72% female).
J Pediatr Gastroenterol Nutr
October 2024
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Neurogastroenterol Motil
December 2024
Division of Gastroenterology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA.
Background: GI-specific psychological factors are important contributors to patients' symptom experience and quality of life across all disorders of gut-brain interaction (DGBI). Clinicians' ability to recognize the role of these psychological factors is essential for formulating a biopsychosocial case conceptualization and informing treatment decisions.
Purpose: This article will familiarize gastroenterology providers with conceptualizing the role of GI-specific psychological factors in DGBI and provides stepwise, practical guidance for how to assess these during clinical encounters in a time-efficient manner.
Dig Dis Sci
December 2024
Johns Hopkins Center for Neurogastroenterology, Baltimore, MD, USA.
Background: Breath testing for small intestinal bacterial overgrowth (SIBO) is typically performed using clinic-based equipment or single-use test kits.
Aims: This study aimed to evaluate the utility of a portable, point-of-care breath analysis device (AIRE®, FoodMarble) in patients suspected to have SIBO. A technical assessment including a comparison to existing mail-in kits was first performed.
Neurogastroenterol Motil
October 2024
Department of Anesthesia, Stanford Medicine Children's Health, Menlo Park, California, USA.
Objective: Cognitive Behavioral Therapy (CBT) for youth with Disorders of Gut-Brain Interaction (DGBIs) is effective; however, there are calls in the field to strengthen the evidence base and identify specific mechanisms of treatment that yield the most benefit for this patient population. A unique, systematic treatment approach of CBT with initial evidence for success for pediatric patients with DGBIs was evaluated to further demonstrate its clinical utility in this population.
Methods: This was a retrospective study of 42 pediatric patients aged 11-17 years with DGBIs, who were diagnosed and referred for CBT by pediatric gastroenterology providers.
Neurogastroenterol Motil
October 2024
Centre for Neuroscience, Surgery and Trauma, Wingate Institute of Neurogastroenterology, Barts and The London School of Medicine and Dentistry, University of London, London, UK.
Background: Patients (20%-50%) with inflammatory bowel disease (IBD) experience chronic abdominal pain during remission. The clinical features of IBD patients with abdominal pain during remission remain poorly characterized. This cross-sectional pilot study aimed to assess patient recruitment, adherence, and feedback to optimize questionnaires for future use and to determine the clinical features that distinguish IBD patients in remission with and without abdominal pain.
View Article and Find Full Text PDFNeurogastroenterol Motil
October 2024
Emma Children's Hospital-Amsterdam UMC, Location University of Amsterdam, Pediatric Gastroenterology, Amsterdam, The Netherlands.
Transition services-programs that support adolescents and young adults (AYAs) as they move from a child-centered to a more autonomous, adult-orientated healthcare system-have been associated with improved short- and long-term healthcare outcomes. Unfortunately, there is a paucity of evidence exploring transition services within the neurogastroenterology and motility (NGM) field. The overall aim of this article, endorsed by the American Neurogastroenterology and Motility Society and European Society of Neurogastroenterology and Motility, is to promote a discussion about the role of transition services for patients with NGM disorders.
View Article and Find Full Text PDFBJOG
December 2024
Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
J Pediatr Gastroenterol Nutr
September 2024
Division of Pediatric Gastroenterology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Objectives: Ineffective esophageal motility (IEM) on high-resolution manometry (HRM) is not consistently associated with specific clinical syndromes or outcomes. We evaluated the prevalence, clinical features, management, and outcomes of pediatric IEM patients across the United States.
Methods: Clinical and manometric characteristics of children undergoing esophageal HRM during 2021-2022 were collected from 12 pediatric motility centers.
United European Gastroenterol J
September 2024
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Background: Patients with organic gastrointestinal (GI) diseases and diabetes mellitus (DM) can have concomitant disorders of gut-brain interaction (DGBI).
Objective: This study aimed to compare the global prevalence of DGBI-compatible symptom profiles in adults with and without self-reported organic GI diseases or DM.
Methods: Data were collected in a population-based internet survey in 26 countries, the Rome Foundation Global Epidemiology Study (n = 54,127).
Neurogastroenterol Motil
September 2024
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
The role of long-term parenteral support in patients with underlying benign conditions who do not have intestinal failure (IF) is contentious, not least since there are clear benefits in utilising the oral or enteral route for nutritional support. Furthermore, the risks of long-term home parenteral nutrition (HPN) are significant, with significant impacts on morbidity and mortality. There has, however, been a recent upsurge of the use of HPN in patients with conditions such as gastro-intestinal neuromuscular disorders, opioid bowel dysfunction, disorders of gut-brain interaction and possibly eating disorders, who do not have IF.
View Article and Find Full Text PDF